

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.58788902 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.37595593 |
| 3 | synaptic vesicle maturation (GO:0016188) | 4.88061653 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.59788418 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.48818124 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.38993736 |
| 7 | detection of calcium ion (GO:0005513) | 4.26370559 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.16244346 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 4.12336806 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.12336806 |
| 11 | regulation of synaptic vesicle transport (GO:1902803) | 4.03693714 |
| 12 | vocalization behavior (GO:0071625) | 4.03096374 |
| 13 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.97105124 |
| 14 | glutamate secretion (GO:0014047) | 3.96579722 |
| 15 | neuronal action potential propagation (GO:0019227) | 3.95543704 |
| 16 | postsynaptic membrane organization (GO:0001941) | 3.84615767 |
| 17 | neurotransmitter secretion (GO:0007269) | 3.82687644 |
| 18 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.80674717 |
| 19 | behavioral response to nicotine (GO:0035095) | 3.78981482 |
| 20 | insulin secretion (GO:0030073) | 3.76865440 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.73984953 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 3.73123987 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.72361245 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.70584168 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.70013454 |
| 26 | serotonin metabolic process (GO:0042428) | 3.65209605 |
| 27 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.60939898 |
| 28 | chemosensory behavior (GO:0007635) | 3.58891129 |
| 29 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.58630877 |
| 30 | presynaptic membrane assembly (GO:0097105) | 3.54023942 |
| 31 | regulation of neurotransmitter uptake (GO:0051580) | 3.53235773 |
| 32 | central nervous system myelination (GO:0022010) | 3.52127818 |
| 33 | axon ensheathment in central nervous system (GO:0032291) | 3.52127818 |
| 34 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.51504383 |
| 35 | protein localization to synapse (GO:0035418) | 3.49415821 |
| 36 | regulation of vesicle fusion (GO:0031338) | 3.48775162 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48275639 |
| 38 | exploration behavior (GO:0035640) | 3.47733412 |
| 39 | glycine transport (GO:0015816) | 3.45759917 |
| 40 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.45465122 |
| 41 | presynaptic membrane organization (GO:0097090) | 3.45448899 |
| 42 | primary amino compound metabolic process (GO:1901160) | 3.40881612 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.40694656 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.39565198 |
| 45 | activation of protein kinase A activity (GO:0034199) | 3.38401716 |
| 46 | positive regulation of membrane potential (GO:0045838) | 3.36139122 |
| 47 | neuromuscular process controlling posture (GO:0050884) | 3.32492831 |
| 48 | protein maturation by protein folding (GO:0022417) | 3.28201109 |
| 49 | peptide hormone processing (GO:0016486) | 3.28109442 |
| 50 | positive regulation of vesicle fusion (GO:0031340) | 3.27753356 |
| 51 | innervation (GO:0060384) | 3.25795275 |
| 52 | proline transport (GO:0015824) | 3.24745445 |
| 53 | neuron-neuron synaptic transmission (GO:0007270) | 3.24470397 |
| 54 | auditory behavior (GO:0031223) | 3.18846452 |
| 55 | long-term memory (GO:0007616) | 3.18382726 |
| 56 | neurotransmitter transport (GO:0006836) | 3.15201001 |
| 57 | glutamate receptor signaling pathway (GO:0007215) | 3.11881351 |
| 58 | cerebellar Purkinje cell layer development (GO:0021680) | 3.11408062 |
| 59 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11176233 |
| 60 | neuronal action potential (GO:0019228) | 3.09699120 |
| 61 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09555808 |
| 62 | positive regulation of exocytosis (GO:0045921) | 3.08142486 |
| 63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.06270971 |
| 64 | regulation of insulin secretion (GO:0050796) | 3.04092504 |
| 65 | neuromuscular synaptic transmission (GO:0007274) | 3.03500146 |
| 66 | potassium ion import (GO:0010107) | 3.03422710 |
| 67 | regulation of exocytosis (GO:0017157) | 3.03222418 |
| 68 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03045938 |
| 69 | regulation of synapse structural plasticity (GO:0051823) | 3.01134651 |
| 70 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.00776596 |
| 71 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.99915691 |
| 72 | glycosphingolipid biosynthetic process (GO:0006688) | 2.98208251 |
| 73 | neurotransmitter uptake (GO:0001504) | 2.97209617 |
| 74 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.96992638 |
| 75 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.96936947 |
| 76 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.96216679 |
| 77 | membrane depolarization during action potential (GO:0086010) | 2.95565711 |
| 78 | membrane depolarization (GO:0051899) | 2.94833084 |
| 79 | vesicle transport along microtubule (GO:0047496) | 2.94792000 |
| 80 | protein targeting to Golgi (GO:0000042) | 2.93187145 |
| 81 | long-term synaptic potentiation (GO:0060291) | 2.93064367 |
| 82 | gamma-aminobutyric acid transport (GO:0015812) | 2.92613393 |
| 83 | regulation of neurotransmitter secretion (GO:0046928) | 2.92459389 |
| 84 | transmission of nerve impulse (GO:0019226) | 2.92307926 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 2.91168524 |
| 86 | signal release (GO:0023061) | 2.90767293 |
| 87 | startle response (GO:0001964) | 2.89879498 |
| 88 | regulation of respiratory system process (GO:0044065) | 2.89604881 |
| 89 | dendritic spine morphogenesis (GO:0060997) | 2.89573602 |
| 90 | regulation of postsynaptic membrane potential (GO:0060078) | 2.89021390 |
| 91 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.88697259 |
| 92 | endocrine pancreas development (GO:0031018) | 2.88425272 |
| 93 | fucose catabolic process (GO:0019317) | 2.87260630 |
| 94 | L-fucose metabolic process (GO:0042354) | 2.87260630 |
| 95 | L-fucose catabolic process (GO:0042355) | 2.87260630 |
| 96 | cellular potassium ion transport (GO:0071804) | 2.87231971 |
| 97 | potassium ion transmembrane transport (GO:0071805) | 2.87231971 |
| 98 | suckling behavior (GO:0001967) | 2.86993383 |
| 99 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.86873217 |
| 100 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.86551973 |
| 101 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.86023399 |
| 102 | positive regulation of insulin secretion (GO:0032024) | 2.84982496 |
| 103 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.83512902 |
| 104 | cellular response to glucagon stimulus (GO:0071377) | 2.83205240 |
| 105 | protein polyglutamylation (GO:0018095) | 2.83202406 |
| 106 | alanine transport (GO:0032328) | 2.82151058 |
| 107 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.81412769 |
| 108 | synaptic transmission (GO:0007268) | 2.81163938 |
| 109 | regulation of neurotransmitter levels (GO:0001505) | 2.81036965 |
| 110 | regulation of beta-amyloid formation (GO:1902003) | 2.80350101 |
| 111 | synaptic vesicle endocytosis (GO:0048488) | 2.79993478 |
| 112 | peptide hormone secretion (GO:0030072) | 2.78127621 |
| 113 | regulation of peptide hormone secretion (GO:0090276) | 2.77374541 |
| 114 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77003584 |
| 115 | regulation of peptide secretion (GO:0002791) | 2.76757999 |
| 116 | calcium ion-dependent exocytosis (GO:0017156) | 2.76216557 |
| 117 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.75405604 |
| 118 | neuron recognition (GO:0008038) | 2.75131389 |
| 119 | inner ear receptor cell development (GO:0060119) | 2.74757351 |
| 120 | retinal cone cell development (GO:0046549) | 2.74661919 |
| 121 | layer formation in cerebral cortex (GO:0021819) | 2.74037217 |
| 122 | C4-dicarboxylate transport (GO:0015740) | 2.73659160 |
| 123 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.72897017 |
| 124 | glycerophospholipid catabolic process (GO:0046475) | 2.72715448 |
| 125 | potassium ion transport (GO:0006813) | 2.72603528 |
| 126 | cell communication by electrical coupling (GO:0010644) | 2.72357748 |
| 127 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.71423194 |
| 128 | protein localization to cilium (GO:0061512) | 2.71405681 |
| 129 | regulation of neurotransmitter transport (GO:0051588) | 2.71128408 |
| 130 | cellular potassium ion homeostasis (GO:0030007) | 2.71059356 |
| 131 | action potential (GO:0001508) | 2.69782130 |
| 132 | peptide secretion (GO:0002790) | 2.69319724 |
| 133 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.68245859 |
| 134 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.68071337 |
| 135 | response to pheromone (GO:0019236) | 2.67959713 |
| 136 | potassium ion homeostasis (GO:0055075) | 2.67853277 |
| 137 | mechanosensory behavior (GO:0007638) | 2.67822504 |
| 138 | regulation of ARF protein signal transduction (GO:0032012) | 2.67692936 |
| 139 | neuronal ion channel clustering (GO:0045161) | 2.67150983 |
| 140 | positive regulation of potassium ion transport (GO:0043268) | 2.66311791 |
| 141 | positive regulation of neurotransmitter transport (GO:0051590) | 2.65616911 |
| 142 | nephron epithelium morphogenesis (GO:0072088) | 2.63593399 |
| 143 | nephron tubule morphogenesis (GO:0072078) | 2.63593399 |
| 144 | negative regulation of neurotransmitter transport (GO:0051589) | 2.63400174 |
| 145 | reflex (GO:0060004) | 2.61101089 |
| 146 | cyclic nucleotide catabolic process (GO:0009214) | 2.59574396 |
| 147 | adult walking behavior (GO:0007628) | 2.58573291 |
| 148 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.56832547 |
| 149 | regulation of action potential (GO:0098900) | 2.56505015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.79263102 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65114164 |
| 3 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90980555 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.87620049 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.67251664 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65421242 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.59469360 |
| 8 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42330506 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.35927240 |
| 10 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.35898328 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33348782 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31541809 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.29608838 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27029408 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25946167 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23097857 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.17578862 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.17578862 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15451080 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04446566 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.03406672 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02993300 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95988589 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94601216 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90619994 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89400653 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.89056210 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86825381 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82628045 |
| 30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81514598 |
| 31 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.80422316 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.73707180 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.73296408 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73100278 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.65995118 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64007489 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63175834 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61631827 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59104600 |
| 40 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58241890 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51622823 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50891344 |
| 43 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.48866282 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48344643 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47200218 |
| 46 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.45271779 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44455136 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41802517 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40442097 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39603032 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39483112 |
| 52 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34956620 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33779755 |
| 54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30819575 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30197852 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30197852 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29486441 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29071134 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27244999 |
| 60 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26989466 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26458397 |
| 62 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26405922 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25642570 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23643169 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22952883 |
| 66 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21864376 |
| 67 | * AR_19668381_ChIP-Seq_PC3_Human | 1.21435102 |
| 68 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21308987 |
| 69 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21308987 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21240604 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20699099 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18847390 |
| 73 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.17515391 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15694165 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15502895 |
| 76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14514608 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.14419404 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13876220 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12692919 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12175584 |
| 81 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12013697 |
| 82 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11012958 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09402110 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07341510 |
| 85 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06908869 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06793077 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06657051 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06525572 |
| 89 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04905062 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04905062 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04773051 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04244840 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03970749 |
| 94 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03679178 |
| 95 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02982376 |
| 96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02852658 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.02654250 |
| 98 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02358758 |
| 99 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02214697 |
| 100 | JUN_21703547_ChIP-Seq_K562_Human | 1.00927969 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00199399 |
| 102 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00097577 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99234544 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99130297 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98919337 |
| 106 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96879987 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95805038 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95741579 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95558857 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95012665 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94215580 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93925879 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93870821 |
| 114 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93491004 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92614231 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92347408 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92021869 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90784994 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89386707 |
| 120 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87551049 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87426167 |
| 122 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85081962 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85048542 |
| 124 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.84436539 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.82206072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.67763757 |
| 2 | MP0004270_analgesia | 3.50954173 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.29245733 |
| 4 | MP0002909_abnormal_adrenal_gland | 3.25627940 |
| 5 | MP0003880_abnormal_central_pattern | 3.18294939 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 2.89097582 |
| 7 | MP0000013_abnormal_adipose_tissue | 2.81991695 |
| 8 | MP0009745_abnormal_behavioral_response | 2.67907844 |
| 9 | MP0010386_abnormal_urinary_bladder | 2.67020511 |
| 10 | MP0002822_catalepsy | 2.60188308 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.58974691 |
| 12 | MP0003283_abnormal_digestive_organ | 2.52390606 |
| 13 | MP0002064_seizures | 2.48801826 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.47910688 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.47590307 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.40683790 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.36487384 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.31029182 |
| 19 | MP0002272_abnormal_nervous_system | 2.31021421 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.30791686 |
| 21 | MP0009046_muscle_twitch | 2.26370180 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.21269314 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.17367165 |
| 24 | MP0003122_maternal_imprinting | 2.16113135 |
| 25 | MP0004043_abnormal_pH_regulation | 2.13918407 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.12297394 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 2.07112071 |
| 28 | MP0002733_abnormal_thermal_nociception | 2.05582292 |
| 29 | MP0002693_abnormal_pancreas_physiology | 2.02989693 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.95455955 |
| 31 | MP0003787_abnormal_imprinting | 1.92810874 |
| 32 | MP0001970_abnormal_pain_threshold | 1.88390248 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.82845683 |
| 34 | MP0001486_abnormal_startle_reflex | 1.82780093 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.75964627 |
| 36 | MP0001944_abnormal_pancreas_morphology | 1.74341723 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.73330990 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.64056490 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.62952886 |
| 40 | MP0004147_increased_porphyrin_level | 1.61036826 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.60514900 |
| 42 | MP0002184_abnormal_innervation | 1.59072390 |
| 43 | MP0002736_abnormal_nociception_after | 1.57984784 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.56087071 |
| 45 | MP0008569_lethality_at_weaning | 1.52092648 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.51231229 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.49933096 |
| 48 | MP0003195_calcinosis | 1.48571108 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.47027800 |
| 50 | MP0003879_abnormal_hair_cell | 1.46759643 |
| 51 | MP0004924_abnormal_behavior | 1.43394546 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.43394546 |
| 53 | MP0008872_abnormal_physiological_respon | 1.42376663 |
| 54 | MP0000955_abnormal_spinal_cord | 1.40131064 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.39773003 |
| 56 | MP0001984_abnormal_olfaction | 1.36052925 |
| 57 | MP0001188_hyperpigmentation | 1.34408251 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.34143139 |
| 59 | MP0001529_abnormal_vocalization | 1.33056591 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.30308216 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.28336363 |
| 62 | MP0004858_abnormal_nervous_system | 1.27898103 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.21793050 |
| 64 | MP0003329_amyloid_beta_deposits | 1.21124832 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 1.20602728 |
| 66 | MP0004742_abnormal_vestibular_system | 1.18975176 |
| 67 | MP0002102_abnormal_ear_morphology | 1.18822229 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.17108122 |
| 69 | MP0003633_abnormal_nervous_system | 1.14827956 |
| 70 | MP0004133_heterotaxia | 1.14612587 |
| 71 | MP0002876_abnormal_thyroid_physiology | 1.14206106 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.14061478 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.12939021 |
| 74 | MP0005535_abnormal_body_temperature | 1.12518292 |
| 75 | MP0000778_abnormal_nervous_system | 1.05525384 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 1.04260807 |
| 77 | MP0000427_abnormal_hair_cycle | 1.04016928 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.00326270 |
| 79 | MP0004145_abnormal_muscle_electrophysio | 1.00262805 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.98623872 |
| 81 | MP0001905_abnormal_dopamine_level | 0.98229711 |
| 82 | MP0002229_neurodegeneration | 0.96357160 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.96018993 |
| 84 | MP0004885_abnormal_endolymph | 0.94398954 |
| 85 | MP0002234_abnormal_pharynx_morphology | 0.93193381 |
| 86 | MP0004142_abnormal_muscle_tone | 0.92867323 |
| 87 | MP0003953_abnormal_hormone_level | 0.92143290 |
| 88 | MP0003646_muscle_fatigue | 0.86473548 |
| 89 | MP0004085_abnormal_heartbeat | 0.85008976 |
| 90 | MP0003631_nervous_system_phenotype | 0.84653428 |
| 91 | MP0002163_abnormal_gland_morphology | 0.84352189 |
| 92 | MP0006292_abnormal_olfactory_placode | 0.81994587 |
| 93 | MP0002752_abnormal_somatic_nervous | 0.79254258 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.78768536 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.78629107 |
| 96 | MP0003632_abnormal_nervous_system | 0.78427588 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.77620701 |
| 98 | MP0003045_fibrosis | 0.76809865 |
| 99 | MP0003123_paternal_imprinting | 0.76172969 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.75404314 |
| 101 | MP0003121_genomic_imprinting | 0.75071476 |
| 102 | MP0000920_abnormal_myelination | 0.75051042 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.74862771 |
| 104 | MP0002152_abnormal_brain_morphology | 0.74774541 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.74252904 |
| 106 | MP0003690_abnormal_glial_cell | 0.73595296 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.71226767 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70255529 |
| 109 | MP0002751_abnormal_autonomic_nervous | 0.69973020 |
| 110 | MP0003634_abnormal_glial_cell | 0.69506705 |
| 111 | MP0001664_abnormal_digestion | 0.69405305 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.68082621 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.67716234 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.64577986 |
| 115 | MP0005253_abnormal_eye_physiology | 0.62673325 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.61683591 |
| 117 | MP0005448_abnormal_energy_balance | 0.61353587 |
| 118 | MP0002090_abnormal_vision | 0.58907647 |
| 119 | MP0005499_abnormal_olfactory_system | 0.58895190 |
| 120 | MP0005394_taste/olfaction_phenotype | 0.58895190 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.58037960 |
| 122 | MP0000569_abnormal_digit_pigmentation | 0.58036267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.88324264 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.52233129 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.72630329 |
| 4 | Visual hallucinations (HP:0002367) | 4.70512305 |
| 5 | Myokymia (HP:0002411) | 4.43023007 |
| 6 | Hypoglycemic seizures (HP:0002173) | 4.22336043 |
| 7 | Focal seizures (HP:0007359) | 4.12058221 |
| 8 | Atonic seizures (HP:0010819) | 3.98120325 |
| 9 | Symptomatic seizures (HP:0011145) | 3.89674272 |
| 10 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.83030711 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.68530573 |
| 12 | Papilledema (HP:0001085) | 3.66402509 |
| 13 | Febrile seizures (HP:0002373) | 3.63515848 |
| 14 | Agitation (HP:0000713) | 3.60927475 |
| 15 | Absence seizures (HP:0002121) | 3.49694747 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.40897307 |
| 17 | Decreased circulating renin level (HP:0003351) | 3.27166309 |
| 18 | Epileptiform EEG discharges (HP:0011182) | 3.25633455 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.24501279 |
| 20 | EEG with generalized epileptiform discharges (HP:0011198) | 3.20900210 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.20845242 |
| 22 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.18207096 |
| 23 | Dialeptic seizures (HP:0011146) | 3.18197718 |
| 24 | Pheochromocytoma (HP:0002666) | 3.11474000 |
| 25 | Hypsarrhythmia (HP:0002521) | 3.09574215 |
| 26 | Nephronophthisis (HP:0000090) | 3.05069828 |
| 27 | Pancreatic cysts (HP:0001737) | 3.03726193 |
| 28 | Action tremor (HP:0002345) | 3.02539287 |
| 29 | Hypothermia (HP:0002045) | 2.99237293 |
| 30 | Anxiety (HP:0000739) | 2.92532035 |
| 31 | Pancreatic fibrosis (HP:0100732) | 2.87013980 |
| 32 | Hyperglycemia (HP:0003074) | 2.84555338 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.83837803 |
| 34 | Depression (HP:0000716) | 2.82876687 |
| 35 | Abnormality of midbrain morphology (HP:0002418) | 2.82080477 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 2.82080477 |
| 37 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.81966671 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 2.81602406 |
| 39 | Abnormal drinking behavior (HP:0030082) | 2.76112148 |
| 40 | Polydipsia (HP:0001959) | 2.76112148 |
| 41 | Large for gestational age (HP:0001520) | 2.75294487 |
| 42 | Neuroendocrine neoplasm (HP:0100634) | 2.74769136 |
| 43 | True hermaphroditism (HP:0010459) | 2.67354437 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.66104492 |
| 45 | Inability to walk (HP:0002540) | 2.62837858 |
| 46 | Polyphagia (HP:0002591) | 2.62366960 |
| 47 | Truncal ataxia (HP:0002078) | 2.61028158 |
| 48 | Abnormality of the renal medulla (HP:0100957) | 2.61021313 |
| 49 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.60821873 |
| 50 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.60821873 |
| 51 | Menstrual irregularities (HP:0000858) | 2.57877488 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.54738342 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.51819133 |
| 54 | Abnormality of binocular vision (HP:0011514) | 2.51533143 |
| 55 | Diplopia (HP:0000651) | 2.51533143 |
| 56 | Ketoacidosis (HP:0001993) | 2.51153778 |
| 57 | Increased circulating renin level (HP:0000848) | 2.48438750 |
| 58 | Progressive inability to walk (HP:0002505) | 2.39575821 |
| 59 | Hyperparathyroidism (HP:0000843) | 2.36365828 |
| 60 | Intestinal atresia (HP:0011100) | 2.34859223 |
| 61 | Ankle clonus (HP:0011448) | 2.33775467 |
| 62 | Amblyopia (HP:0000646) | 2.32307896 |
| 63 | Failure to thrive in infancy (HP:0001531) | 2.30319723 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.29933425 |
| 65 | Dysautonomia (HP:0002459) | 2.24192228 |
| 66 | Abnormality of renin-angiotensin system (HP:0000847) | 2.22399916 |
| 67 | Poor eye contact (HP:0000817) | 2.20382571 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.19926194 |
| 69 | Hemiparesis (HP:0001269) | 2.19148943 |
| 70 | Lissencephaly (HP:0001339) | 2.18899654 |
| 71 | Hypercortisolism (HP:0001578) | 2.18291325 |
| 72 | Attenuation of retinal blood vessels (HP:0007843) | 2.17738549 |
| 73 | Methylmalonic acidemia (HP:0002912) | 2.17061285 |
| 74 | Status epilepticus (HP:0002133) | 2.15946567 |
| 75 | Excessive salivation (HP:0003781) | 2.15321302 |
| 76 | Drooling (HP:0002307) | 2.15321302 |
| 77 | Hyperventilation (HP:0002883) | 2.15153696 |
| 78 | Hypokalemia (HP:0002900) | 2.14336586 |
| 79 | Blue irides (HP:0000635) | 2.13536822 |
| 80 | Hemiplegia (HP:0002301) | 2.11750843 |
| 81 | Cortical visual impairment (HP:0100704) | 2.09724553 |
| 82 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09478913 |
| 83 | Abnormal pancreas size (HP:0012094) | 2.09157711 |
| 84 | Hyperkalemia (HP:0002153) | 2.07681267 |
| 85 | Dysmetria (HP:0001310) | 2.06968908 |
| 86 | Dysdiadochokinesis (HP:0002075) | 2.06536571 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.05724995 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05724995 |
| 89 | Broad-based gait (HP:0002136) | 2.05709786 |
| 90 | Polyuria (HP:0000103) | 2.04282766 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.04062457 |
| 92 | Renal cortical cysts (HP:0000803) | 2.03261074 |
| 93 | Impaired social interactions (HP:0000735) | 2.02971720 |
| 94 | Abnormal social behavior (HP:0012433) | 2.02971720 |
| 95 | Dysostosis multiplex (HP:0000943) | 2.02486041 |
| 96 | Postural instability (HP:0002172) | 2.01204180 |
| 97 | Type II lissencephaly (HP:0007260) | 1.99987335 |
| 98 | Restlessness (HP:0000711) | 1.99932043 |
| 99 | Postural tremor (HP:0002174) | 1.99861208 |
| 100 | Torticollis (HP:0000473) | 1.99503987 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.99001328 |
| 102 | Genital tract atresia (HP:0001827) | 1.98912495 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 1.98563620 |
| 104 | Abnormality of potassium homeostasis (HP:0011042) | 1.98453570 |
| 105 | Cystic liver disease (HP:0006706) | 1.98377678 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98114394 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98114394 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98114394 |
| 109 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.97910211 |
| 110 | Late onset (HP:0003584) | 1.96837091 |
| 111 | Abnormal eating behavior (HP:0100738) | 1.94653515 |
| 112 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.94596708 |
| 113 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.94596708 |
| 114 | Chronic hepatic failure (HP:0100626) | 1.93377167 |
| 115 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92553398 |
| 116 | Cerebellar dysplasia (HP:0007033) | 1.91868937 |
| 117 | Vaginal atresia (HP:0000148) | 1.90898531 |
| 118 | Hyperphosphatemia (HP:0002905) | 1.89448876 |
| 119 | Abnormality of vitamin B metabolism (HP:0004340) | 1.88688835 |
| 120 | Gait imbalance (HP:0002141) | 1.87969809 |
| 121 | Bradykinesia (HP:0002067) | 1.87609565 |
| 122 | Retinal dysplasia (HP:0007973) | 1.87388389 |
| 123 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86867217 |
| 124 | Tubular atrophy (HP:0000092) | 1.86138464 |
| 125 | Neurofibrillary tangles (HP:0002185) | 1.86098897 |
| 126 | Absent speech (HP:0001344) | 1.85504253 |
| 127 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83458114 |
| 128 | Genetic anticipation (HP:0003743) | 1.82661267 |
| 129 | Osteomalacia (HP:0002749) | 1.82268587 |
| 130 | Spastic gait (HP:0002064) | 1.82041408 |
| 131 | Psychosis (HP:0000709) | 1.81761851 |
| 132 | Limb dystonia (HP:0002451) | 1.81578573 |
| 133 | Adrenal overactivity (HP:0002717) | 1.81039007 |
| 134 | Fair hair (HP:0002286) | 1.81006095 |
| 135 | Prolonged QT interval (HP:0001657) | 1.78301212 |
| 136 | Widely spaced teeth (HP:0000687) | 1.78106360 |
| 137 | Muscular hypotonia of the trunk (HP:0008936) | 1.77674798 |
| 138 | Abnormal EKG (HP:0003115) | 1.77581971 |
| 139 | Specific learning disability (HP:0001328) | 1.77376637 |
| 140 | Cerebral inclusion bodies (HP:0100314) | 1.77120058 |
| 141 | Macroorchidism (HP:0000053) | 1.76609654 |
| 142 | Focal dystonia (HP:0004373) | 1.76493458 |
| 143 | Methylmalonic aciduria (HP:0012120) | 1.75385221 |
| 144 | Abnormality of macular pigmentation (HP:0008002) | 1.75253600 |
| 145 | Abnormality of the labia minora (HP:0012880) | 1.74789491 |
| 146 | Hyperactive renin-angiotensin system (HP:0000841) | 1.74232771 |
| 147 | Protruding tongue (HP:0010808) | 1.73407377 |
| 148 | Hypotension (HP:0002615) | 1.73142805 |
| 149 | Pachygyria (HP:0001302) | 1.73138169 |
| 150 | Clumsiness (HP:0002312) | 1.72038361 |
| 151 | Decreased central vision (HP:0007663) | 1.71912655 |
| 152 | Generalized hypopigmentation of hair (HP:0011358) | 1.70891725 |
| 153 | Sleep apnea (HP:0010535) | 1.70166210 |
| 154 | Keratoconus (HP:0000563) | 1.69961905 |
| 155 | Increased corneal curvature (HP:0100692) | 1.69961905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.32673945 |
| 2 | INSRR | 3.63167928 |
| 3 | PRKD3 | 3.04936683 |
| 4 | EPHA4 | 2.84066858 |
| 5 | MAP3K9 | 2.68245772 |
| 6 | NTRK1 | 2.59514229 |
| 7 | MAP3K4 | 2.56341924 |
| 8 | MAPK15 | 2.49490338 |
| 9 | MAP4K2 | 2.41637154 |
| 10 | MAP2K7 | 2.36130240 |
| 11 | MAP3K2 | 2.26807315 |
| 12 | WNK3 | 2.12773037 |
| 13 | ADRBK2 | 2.09958036 |
| 14 | MINK1 | 2.03883462 |
| 15 | MARK1 | 1.97919099 |
| 16 | TAOK3 | 1.97064722 |
| 17 | GRK1 | 1.94898776 |
| 18 | UHMK1 | 1.86819332 |
| 19 | PASK | 1.78594511 |
| 20 | CAMKK2 | 1.73120345 |
| 21 | KSR2 | 1.72097721 |
| 22 | OXSR1 | 1.70104215 |
| 23 | HIPK2 | 1.64159761 |
| 24 | NTRK2 | 1.55426478 |
| 25 | RIPK4 | 1.52715290 |
| 26 | TNIK | 1.50036119 |
| 27 | DAPK2 | 1.48282517 |
| 28 | CASK | 1.44638791 |
| 29 | BMPR1B | 1.44622643 |
| 30 | CAMKK1 | 1.44258191 |
| 31 | MAP3K1 | 1.41378818 |
| 32 | PAK6 | 1.41256216 |
| 33 | PNCK | 1.40331486 |
| 34 | MAP2K4 | 1.40306765 |
| 35 | WNK4 | 1.39349087 |
| 36 | MAP2K6 | 1.38632077 |
| 37 | GRK5 | 1.38620804 |
| 38 | MAP3K12 | 1.31777257 |
| 39 | CDK5 | 1.31472098 |
| 40 | FGFR2 | 1.30519148 |
| 41 | STK39 | 1.27631631 |
| 42 | ACVR1B | 1.22871017 |
| 43 | PRKCH | 1.21984428 |
| 44 | CDC42BPA | 1.21503757 |
| 45 | ARAF | 1.16931077 |
| 46 | MAPK13 | 1.14290193 |
| 47 | AKT3 | 1.12763041 |
| 48 | PRKCG | 1.10563108 |
| 49 | BMPR2 | 1.09224774 |
| 50 | MAPKAPK5 | 1.09199038 |
| 51 | SCYL2 | 1.09143568 |
| 52 | DAPK1 | 1.06652815 |
| 53 | FRK | 1.06263495 |
| 54 | WNK1 | 1.04686792 |
| 55 | SGK494 | 1.03152488 |
| 56 | SGK223 | 1.03152488 |
| 57 | SGK2 | 1.01136700 |
| 58 | ZAK | 0.97065359 |
| 59 | PAK3 | 0.94929239 |
| 60 | CAMK2B | 0.94515001 |
| 61 | CAMK2A | 0.92059963 |
| 62 | MKNK2 | 0.91590453 |
| 63 | STK38 | 0.90364209 |
| 64 | FES | 0.89337563 |
| 65 | CSNK1G3 | 0.87067712 |
| 66 | KSR1 | 0.86902609 |
| 67 | PRKCE | 0.86811054 |
| 68 | RET | 0.82754427 |
| 69 | NEK6 | 0.82384021 |
| 70 | CAMK2D | 0.79758325 |
| 71 | FER | 0.79499541 |
| 72 | MAPKAPK3 | 0.79355004 |
| 73 | PLK2 | 0.77250894 |
| 74 | CSNK1G1 | 0.75639297 |
| 75 | TLK1 | 0.74605070 |
| 76 | PRPF4B | 0.73923989 |
| 77 | NUAK1 | 0.72417006 |
| 78 | SGK3 | 0.68810530 |
| 79 | PTK2B | 0.68541001 |
| 80 | CSNK1A1L | 0.67943492 |
| 81 | DYRK2 | 0.67694960 |
| 82 | STK38L | 0.67175468 |
| 83 | CAMK1 | 0.67034206 |
| 84 | BRAF | 0.65984968 |
| 85 | SGK1 | 0.65769648 |
| 86 | MARK2 | 0.63245787 |
| 87 | DYRK1A | 0.61619788 |
| 88 | MAP3K13 | 0.61280561 |
| 89 | PKN1 | 0.60259999 |
| 90 | TRIM28 | 0.60183490 |
| 91 | PRKD2 | 0.60017569 |
| 92 | PINK1 | 0.59231100 |
| 93 | PRKCZ | 0.56008009 |
| 94 | GRK7 | 0.55782033 |
| 95 | CSNK1D | 0.53741668 |
| 96 | BRSK1 | 0.52898993 |
| 97 | TNK2 | 0.51731666 |
| 98 | PDGFRA | 0.51557004 |
| 99 | CCNB1 | 0.48716276 |
| 100 | MAP2K1 | 0.48590516 |
| 101 | RPS6KA2 | 0.48344568 |
| 102 | CSNK1G2 | 0.48309752 |
| 103 | PRKG1 | 0.48150260 |
| 104 | TRPM7 | 0.47630067 |
| 105 | CAMK4 | 0.47360795 |
| 106 | RPS6KA3 | 0.47191427 |
| 107 | PRKAA1 | 0.46925843 |
| 108 | IRAK1 | 0.46884667 |
| 109 | ALK | 0.44449467 |
| 110 | CDK14 | 0.44130018 |
| 111 | PTK2 | 0.44120347 |
| 112 | PHKG1 | 0.43909237 |
| 113 | PHKG2 | 0.43909237 |
| 114 | MAPK10 | 0.43265428 |
| 115 | PRKACA | 0.41976468 |
| 116 | CAMK1G | 0.41789948 |
| 117 | STK11 | 0.41603164 |
| 118 | CAMK2G | 0.40762460 |
| 119 | SIK2 | 0.40312674 |
| 120 | CDK18 | 0.39988294 |
| 121 | CSNK1A1 | 0.39636386 |
| 122 | TIE1 | 0.39556957 |
| 123 | TXK | 0.39194169 |
| 124 | PDPK1 | 0.38903935 |
| 125 | IRAK2 | 0.38618151 |
| 126 | CAMK1D | 0.38376866 |
| 127 | PDK1 | 0.37753543 |
| 128 | PIK3CA | 0.37508715 |
| 129 | CDK15 | 0.37386623 |
| 130 | ERBB3 | 0.35968192 |
| 131 | EPHA3 | 0.35863464 |
| 132 | CDK19 | 0.35584353 |
| 133 | PRKCQ | 0.35394447 |
| 134 | PRKCA | 0.35031586 |
| 135 | PRKACB | 0.34940006 |
| 136 | BCR | 0.34278160 |
| 137 | PRKCB | 0.33945461 |
| 138 | MAPK12 | 0.33436456 |
| 139 | ADRBK1 | 0.33171332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.84797791 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 3.19163570 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.95688087 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.86648407 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.57048549 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.51720489 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46063527 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.39771469 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.31121021 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.17429339 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17304851 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.12091479 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11711491 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.11436277 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 2.10670215 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 2.08289140 |
| 17 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.05191449 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87272459 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85362751 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82466416 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80731781 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.76575176 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.75352297 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.67077211 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65543407 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.62487608 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.61965076 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55059535 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51127688 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.50469111 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.50315388 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48971332 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34606038 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33917683 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28901995 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27170305 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.26841112 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26452480 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.26238668 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24455973 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.24101820 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21836159 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18650655 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16525880 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14845477 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14640425 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14278206 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13468802 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07845533 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.07243633 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06534651 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.04866823 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02938380 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00999132 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00442872 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98168132 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91149510 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91133818 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.90802840 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89303145 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88146343 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87467944 |
| 63 | Melanogenesis_Homo sapiens_hsa04916 | 0.84655667 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81873893 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81465119 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78088225 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76445321 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.74986221 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73202248 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72801752 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71667290 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68850597 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.67656197 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67482020 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.65803405 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64887604 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63618317 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61923287 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.61488928 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61429084 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60687014 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60371494 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.60127216 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.59699918 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59491121 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.59182011 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58351288 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56945349 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55896566 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54186435 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51999456 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.51633087 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51514353 |
| 94 | Axon guidance_Homo sapiens_hsa04360 | 0.51404742 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50917222 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49947961 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49866740 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47735895 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47256894 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46861458 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46737852 |
| 102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46257546 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46057944 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44168720 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42973749 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42132443 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40830804 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40579137 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39873549 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38963360 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37852673 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36880941 |
| 113 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36058167 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36027748 |
| 115 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.35879199 |
| 116 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35667807 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35662532 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35325681 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.34731747 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30956449 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30644496 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30283771 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30089008 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29495754 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.29394095 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29376332 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28945961 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.27858149 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26247344 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26084157 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26008678 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24712676 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24030745 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23840200 |

